• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of an osteoporosis model pro-culture by immunity restraint agent and molecular biology analysis of bone absorption mechanism

Research Project

Project/Area Number 15592108
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Surgical dentistry
Research InstitutionOKAYAMA UNIVERSITY

Principal Investigator

FUKUNAGA Jyoji  Okayama University, Graduate School of Medicine and Dentistry, Assistant, 大学院・医歯学総合研究科, 助手 (10284069)

Co-Investigator(Kenkyū-buntansha) TSUJIGIWA Hidetugu  Okayama University, Graduate School of Medicine and Dentistry, Assistant, 大学院・医歯学総合研究科, 助手 (70335628)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2004: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2003: ¥2,200,000 (Direct Cost: ¥2,200,000)
Keywordsosteoporosis / Immunosuppresant agents / osteoclast / T, B細胞 / 骨代謝マーカー / FACS / T細胞 / 3次元マイクロCT
Research Abstract

Blood and urine analysis : Although the level of serum calcium remained mostly within the normal range for both groups, there was a significant increase in the level of urinary Ca for the FK506 treated group from Week 1 of administration. The level of blood osteocalcin for the FK506 treated group at Week 1 of administration was significantly higher than that for the control group, but there was no significant difference after that. Throughout the administration period, the sum of urinary PYD and Dpd for the FK506 treated group was significantly higher. Of the various bone resorption factors, the level of blood PTH for the FK506 treated group was significantly higher than that for the control group at Week 3 of administration and later.
Cell culture : After acclimatization for a week, mice were randomly divided into two groups and were intraperitoneally injected every day either FK506 at a dose of 1mg/kg/day (FK506 treated group) or physiological saline at 10ml/kg/day (Control group). Pr … More ograf, a solution containing 5mg FK506/ml, was diluted in physiological saline to obtain a final concentration. bone marrow cells were collected by flushing femoral shafts using sterile needles. Cells plated in 24-well plates were cultured for 6 days in α-minimal essential medium supplemented with 10% fetal bovine serum, 100U/ml penicillin, and 100 μg/ml streptomycin, 30 ng/ml macrophage-colony stimulating factor, and 100 ng/ml soluble Receptor Activator of NFκB Ligand. TRAP assay : Staining for tartrate-resistant acid phosphatase(TRAP) activity, a leukocyte acid phosphatase assay kit was used. At the end of the culture period, TRAP positive cells exhibiting ≧3 nuclei were counted as mature osteoclasts and TRAP positive cells with <3 nuclei were considered osteoclast precursors. Resorption pit assay : Osteoclasts were seeded onto dentine slices placed in each well of 24-well plates, and after the cells were scraped off from the dentine slices, excavated pits were stained with acid hematoxylin Photographs were taken under a light microscope at ×40 magnification, and total areas of resorption pits were analyzed by the computer soft of NIH Image. Less

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (14 results)

All 2004 Other

All Journal Article (5 results) Book (2 results) Publications (7 results)

  • [Journal Article] Expression of Osteoclast Differentiation Factor and Osteoclastogenesis Inhibitory Factor in Rat Osteoporosis Induced by Immunosuppressant FK5062004

    • Author(s)
      Jyoji Fukunaga, Toshio Sugahara et al.
    • Journal Title

      Bone 34(3)

      Pages: 425-431

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] REGULATION OF BONE METABOLISM IN IMMUNOSUPPRESSANT FK506 TREATED RATS2004

    • Author(s)
      Jyoji Fukunaga, Shiho Kirino
    • Journal Title

      Journal of Bone and Mineral Metabolism 22

      Pages: 554-560

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Annual Research Report 2004 Final Research Report Summary
  • [Journal Article] Expression of Osteoclast Differentiation Factor (RANKL) and Osteoclastogenesis Inhibitory Factor (OPG) in Rat Osteoporosis Induced by Immunosuppressant FK506.2004

    • Author(s)
      Jyoji Fukunaga, Yuichirou Yamaai, Eiki Yamachika, Yuzou Ishiwari, Hidetugu Tsujigiwa, Koichi Sawaki, Y.J.Lee, Takaaki Ueno, Shiho Kirino, Nobuyoshi Mizukawa, Shin Takagi, Noriyuki Nagai, Toshio Sugahara
    • Journal Title

      BONE 34

      Pages: 425-431

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] REGULATION OF BONE METABOLISM IN IMMUNOSUPPRESSANT FK506 TREATED RATS.2004

    • Author(s)
      SHIHO KIRINO, JYOJI FUKUNAGA, SHUJI IKEGAMI, HIROSHI TSUBOI, MASATAKA KIMATA, NAOKI NAKATA, MAKOTO NAKANO, TAKAAKI UENO, NOBUYOSHI MIZUKAWA, TOSHIO SUGAHARA
    • Journal Title

      Journal of Bone and Mineral Metabolism 22

      Pages: 554-560

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Journal Article] Pathological change of articular cartilage in the mandibular head treated with immunosuppressant FK5062004

    • Author(s)
      Jyoji Fukunaga, Takaaki Ueno et al.
    • Journal Title

      Histology and Histopathology 19

      Pages: 15-21

    • Related Report
      2004 Annual Research Report
  • [Book] 骨粗鬆症学-基礎・臨床研究の新しいパラダイム 免疫抑制剤が引き起こす骨粗鬆症2004

    • Author(s)
      福永城司, 菅原利夫
    • Publisher
      日本臨床社
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2004 Final Research Report Summary
  • [Book] 骨粗鬆症学-基礎・臨床研究の新しいパラダイム 免疫抑制剤が引き起こす骨粗鬆症2004

    • Author(s)
      福永城司, 菅原利夫
    • Total Pages
      3
    • Publisher
      日本臨床社62巻増刊号2
    • Related Report
      2004 Annual Research Report
  • [Publications] Jyoji Fukunaga, Toshio Sugahara et al.: "Expression of Osteoclast Differentiation Factor and Osteoclastogenesis Inhibitory Factor in Rat Osteoporosis Induced by Immunosuppressant FK506"Bone. 34(3). 425-431 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Jyoji Fukunaga, Takaaki Ueno et al.: "Pathological change of articular cartilage in the mandibular head treated with immunosuppressant FK506"Histology and Histopathology. 19. 15-21 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Jyoji Fukunaga, Makoto Nakano et al.: "Expression Pattern of Cisplatin-Induced Metallothionein Isoforms in Squamous Cell Carcinoma"Anticancer Research. 23. 299-304 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Jyoji Fukunaga, Takaaki Ueno et al.: "Immunohistochemical observations of cellular differentiation and proliferation in endochondral bone formation from grafted periosteum"Journal of Cranio-Maxillofacial Surgery. 31. 356-361 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Jyoji Fukunaga, Takaaki Ueno et al.: "Vascular Endothelial Growth Factor (VEGF) and Bone Morphogenetic Protein-4 (BMP-4) in Endochondra Ossification from Grafted Periosteum"Acta Histochemistry Cytochemistry. 36(1). 61-66 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Jyoji Fukunaga, Takaaki Ueno et al.: "Regeneartion of Mandibular Head from Grafted Periosteum"Annals Plastic Surgery. 51(1). 77-83 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 福永城司, 菅原利夫: "骨粗鬆症学-基礎・臨床研究の新しいパラダイム免疫抑制剤が引き起こす骨粗鬆症"日本臨床社62巻増刊号2. 3 (2004)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi